Keyword: generic drugs

News

Mylan Said to Prepare Poison Pill Potion Against Teva

24.04.2015 - US-managed generics drugmaker Mylan, now domiciled in the Netherlands, is said to be preparing a "poison pill" defense to escape its pursuit by Israeli generics giant Teva. Teva...

Plant Construction & Process Technology

Quality and Efficiency in Pharma Manufacturing

23.03.2015 - The pharmaceutical industry is confronting a variety of new and complex challenges in the face of globalization and changing market dynamics. The past decade has witnessed a...

Strategy & Management

Camelot’s Pharma Management Radar

19.01.2015 - Despite a positive estimation of the current business climate and an increasing number of products in the pipeline, the global pharmaceutical industry is looking for ways to...

News

Teva to Name New Chairman?

15.07.2014 - Teva Pharmaceutical Industries board is to appoint vice-chairman Amir Elstein as its new chairman, activist shareholder Benny Landa has said. "I was informed by Moshe Many, Amir...

Plant Construction & Process Technology

Preparing for Tomorrow’s Pharmaceutical Challenges

08.06.2014 - The pharmerging markets will still be extending their progress by 10 to 13%, as population increases and rising incomes contribute to dramatically higher use of medicines. Improved...

Plant Construction & Process Technology

Preparing for Tomorrow’s Pharmaceutical Challenges

09.05.2014 - New legislation, expiring patents and increasing healthcare costs call for decisive changes in the global pharmaceutical industry. New markets for specialty medicines...

News

Actavis Sues FDA Over Generic of Pfizer’s Celebrex

29.04.2014 - Generics producer Actavis has sued the U.S. Food and Drug Administration, challenging its decision to award exclusive rights to Israel's Teva to sell a generic version of Pfizer's...

Strategy & Management

Camelot’s Pharma Management Radar

23.04.2014 - Power Of The Unknown - Despite a generally positive estimation of the current business climate, global pharmaceutical companies face challenges that endanger their business...